Discover Antimicrobial Stewardship

Together, we can change the course of antibiotic resistance

The threat of drug-resistant bacteria continues to grow — and so does our commitment  to helping you combat this global issue. As a
leader in diagnostics for more than 50 years, we have made it our mission to innovate and advocate for better antibiotic stewardship. 

Discover how Roche can help you bring insights and innovative solutions to your institution’s antibiotic stewardship program.

alt

 

Antibiotics are an important treatment option, but their misuse is causing devastating impact.

alt

We’re committed to helping you advance your antibiotic stewardship efforts.

Our long-term strategy to help improve patient lives includes:

Substantial investments in numerous assays that help clinicians make more effective treatment decisions using antibiotics or antivirals

Educational support for healthcare providers so they can successfully comply with new regulatory mandates

A deep-seated commitment to promote and implement principles of good antibiotic stewardship

Learn about Global AMR Challenge

 

alt

Roche offers a broad portfolio of products which can enable better clinical decisions and therefore appropriate antibiotic use.
Click on the products below to learn more!

alt

cobas® Liat® PCR System

Treat common infections with confidence at the earliest possible convenience.

alt

Elecsys® BRAHMS PCT Assay

 

alt

cobas® MRSA/SA | Cdiff Tests

Identify and contain healthcare-associated infections (HAIs).

Accuracy and speed that 
support antibiotic stewardship

This CLIA-waived system is uniquely positioned to provide accurate, actionable results at the point of care. Whether results are positive or negative, you can confidently treat patients without the need to wait for confirmation.

✓ Influenza A/B
✓ RSV
✓ Group A Strep
 

See more

Help determine if antibiotics are needed or if certain bacterial infections are resolving.

The Elecsys BRAHMS PCT solution aids in assessing the mortality risk of patients fighting sepsis and guiding antibiotic decision-making for patients with lower respiratory tract infections, like pneumonia, bronchitis, COPD and sepsis.5,6

 

See more

Timely and cost-effective molecular solutions for improved HAI management

The cobas MRSA/SA and Cdiff tests provide provide excellent performance and broad coverage to increase confidence in HAI testing. Run on the fully automated cobas 4800 system, these assays may help your institution control infections and costs.

✓ Decrease transmission
✓ Reduce antibiotic use over time
 

cobas® MRSA/SA Test

cobas® Cdiff Test

alt

 

Want to learn more?  Click on the webinar links below.

alt

A New Year's Resolution:
Become a Better Antibiotic Steward

Watch now

alt

Procalcitonin Testing and Molecular Pathogen Detection:
A Value Model

Watch now

alt

Influenza Testing:
Impact of New Testing and New Testing Options

Watch now

alt

External links and resources to help you with your Antimicrobial Stewardship initiatives

SHEA-logo
Want to learn more about Roche products and solutions to better enable Antimicrobial Stewardship?
CONTACT US

References

1 Centers for Disease Control and Prevention.    https://www.cdc.gov/drugresistance/biggest-threats.html, accessed October 23, 2019

2 Centers for Disease Control and Prevention. “1 in 3 antibiotic prescriptions unnecessary.” CDC Newsroom. https://www.cdc.gov/antibiotic-use/stewardship-report/outpatient.htmll (accessed October  23, 2019).

3 IMS Health. Avoidable Costs in U.S. Healthcare. Danbury, CT: IMS Health; 2013. 

4 Centers for Disease Control and Prevention.  https://www.cdc.gov/hai/data/portal/index.html, accessed October 23, 2019

5 Elecsys BRAHMS PCT [package insert]. Indianapolis, IN: Roche Diagnostics; 2016.

6 Elecsys BRAHMS PCT antibiotic initiation and deescalation claims are pending 510(k) clearance.

 

COBAS, LIAT, ELECSYS and VIEWICS are trademarks of Roche.

© 2019 Roche Diagnostics, North America. All rights reserved.